Physician profile
Mark A Rothstein
NPI 1063417848
$889.53
in general payments reported to CMS, 2019-2025
11 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $137 · 2021: $121 · 2022: $103 · 2023: $145 · 2024: $222 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $305.76 | 2020-2025 | Clareon Panoptix Pro, Clareon, Hydrus Microstent |
| Abbvie INC. | $297.78 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Johnson & Johnson Surgical Vision, INC. | $66.87 | 2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Thea Pharma INC. | $40.35 | 2023-2024 | Iyuzeh |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $32.66 | 2024 | Eylea Hd |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.36 | 2020 | |
| Bausch & Lomb Americas INC. | $23.35 | 2023 | Xipere |
| Harrow Eye, LLC | $20.99 | 2024 | |
| Amgen INC. | $17.75 | 2025 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $14.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rothstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.